MX2014008995A - Compuesto novedoso de ester de acido acetico o una sal del mismo. - Google Patents

Compuesto novedoso de ester de acido acetico o una sal del mismo.

Info

Publication number
MX2014008995A
MX2014008995A MX2014008995A MX2014008995A MX2014008995A MX 2014008995 A MX2014008995 A MX 2014008995A MX 2014008995 A MX2014008995 A MX 2014008995A MX 2014008995 A MX2014008995 A MX 2014008995A MX 2014008995 A MX2014008995 A MX 2014008995A
Authority
MX
Mexico
Prior art keywords
salt
acetic acid
acid ester
ester compound
novel acetic
Prior art date
Application number
MX2014008995A
Other languages
English (en)
Other versions
MX355337B (es
Inventor
Yoshikazu Iwasawa
Masato Nanri
Fukumitsu Sakakibara
Shinichi Aoki
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MX2014008995A publication Critical patent/MX2014008995A/es
Publication of MX355337B publication Critical patent/MX355337B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe un compuesto de éster de ácido acético representado por la siguiente fórmula (I) o una sal del mismo, (ver Fórmula) en donde R representa alquilo inferior deuterizado opcionalmente sustituido.
MX2014008995A 2012-01-30 2013-01-25 Compuesto novedoso de ester de acido acetico o una sal del mismo. MX355337B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012016685 2012-01-30
PCT/JP2013/051533 WO2013115077A1 (ja) 2012-01-30 2013-01-25 新規な酢酸エステル化合物又はその塩

Publications (2)

Publication Number Publication Date
MX2014008995A true MX2014008995A (es) 2014-08-27
MX355337B MX355337B (es) 2018-04-13

Family

ID=48905117

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014008995A MX355337B (es) 2012-01-30 2013-01-25 Compuesto novedoso de ester de acido acetico o una sal del mismo.

Country Status (22)

Country Link
US (2) US9505717B2 (es)
EP (1) EP2810936B1 (es)
JP (1) JP5557965B2 (es)
KR (1) KR101696528B1 (es)
CN (1) CN104093707B (es)
AU (1) AU2013216198B2 (es)
BR (1) BR112014017272B1 (es)
CA (1) CA2862990C (es)
DK (1) DK2810936T3 (es)
ES (1) ES2659269T3 (es)
HK (1) HK1201522A1 (es)
HU (1) HUE036534T2 (es)
MX (1) MX355337B (es)
MY (1) MY168434A (es)
NO (1) NO2810936T3 (es)
PL (1) PL2810936T3 (es)
PT (1) PT2810936T (es)
RU (1) RU2585759C2 (es)
SG (1) SG11201403142PA (es)
TR (1) TR201802133T4 (es)
TW (1) TWI488626B (es)
WO (1) WO2013115077A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104876854B (zh) * 2015-04-16 2017-03-01 御盛隆堂药业有限责任公司 羟基乙酸酯衍生物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD106642A1 (es) * 1973-03-02 1974-06-20
DD139212A1 (de) * 1978-10-09 1979-12-19 Christian Starke Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten
JPH0611758B2 (ja) * 1985-08-14 1994-02-16 大鵬薬品工業株式会社 ベンジル酸−4−ピペリジルエステル誘導体
JPH0669068B2 (ja) 1985-08-30 1994-08-31 株式会社東芝 多層配線の製造方法
DE10129832A1 (de) * 2001-06-17 2003-07-10 Berolina Drug Dev Ab Svedala Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
TWI488626B (zh) 2015-06-21
RU2585759C2 (ru) 2016-06-10
BR112014017272A8 (pt) 2017-07-04
DK2810936T3 (en) 2018-02-12
TR201802133T4 (tr) 2018-03-21
AU2013216198B2 (en) 2016-01-21
SG11201403142PA (en) 2014-10-30
US9907792B2 (en) 2018-03-06
TW201334781A (zh) 2013-09-01
CN104093707B (zh) 2016-01-06
CA2862990A1 (en) 2013-08-08
EP2810936B1 (en) 2017-11-22
BR112014017272A2 (pt) 2017-06-13
NO2810936T3 (es) 2018-04-21
US9505717B2 (en) 2016-11-29
RU2014135417A (ru) 2016-03-27
AU2013216198A1 (en) 2014-07-10
HUE036534T2 (hu) 2018-07-30
PT2810936T (pt) 2018-02-16
WO2013115077A1 (ja) 2013-08-08
US20140371270A1 (en) 2014-12-18
ES2659269T3 (es) 2018-03-14
EP2810936A4 (en) 2015-05-13
HK1201522A1 (zh) 2015-09-04
JP5557965B2 (ja) 2014-07-23
MY168434A (en) 2018-11-09
EP2810936A1 (en) 2014-12-10
CA2862990C (en) 2017-10-24
KR101696528B1 (ko) 2017-01-13
PL2810936T3 (pl) 2018-04-30
MX355337B (es) 2018-04-13
JPWO2013115077A1 (ja) 2015-05-11
US20170042875A1 (en) 2017-02-16
KR20140117643A (ko) 2014-10-07
BR112014017272B1 (pt) 2020-10-27
CN104093707A (zh) 2014-10-08

Similar Documents

Publication Publication Date Title
RS54730B1 (sr) Inhibitori beta sekretaze
MX351513B (es) Compuesto de alquinilbenceno 3,5-disustituido y sales del mismo.
RS52171B (en) NALMEFEN DI-ESTER PRODUCTS
PH12016501079A1 (en) (6S,9aS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]-4,7-DIOXO-8-({6-[3-(PIPERAZINE-1-YL)AZETIDINE-1-YL]PYRIDINE-2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO[2,1-c][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND
ES2485825T3 (es) Intermedio de rosuvastatina cálcica y método de preparación del mismo
TN2013000347A1 (en) Production method of optically active dihydrobenzofuran derivative
AU2012310674B2 (en) Radioactive fluorine labeled compound
MX2015012743A (es) Compuesto de pirazol-amida y sus usos farmaceuticos.
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
MY178150A (en) Novel benzoic acid amide compound
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
IN2015DN00446A (es)
IN2012DE00620A (es)
IN2014CN04960A (es)
IN2014DN07996A (es)
PH12016500461A1 (en) Polyethylene glycol-containing composition
EP2578617A4 (en) NYLON CONNECTION
PH12015501146A1 (en) Hydantoin derivative
MX2016016479A (es) Metodo para producir un pentapeptido sintetico.
MX364529B (es) Nuevos ligandos del receptor de estrógeno.
IN2012DN03104A (es)
TN2014000329A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
MX2014008995A (es) Compuesto novedoso de ester de acido acetico o una sal del mismo.

Legal Events

Date Code Title Description
FG Grant or registration